Germany’s Bayer named Pfizer executive Olivier Brandicourt as the new head of its healthcare division, where he will oversee the market launch of a range of potential blockbusters. He will take over from Bayer Healthcare interim head Wolfgang Plischke on Nov. 1, Germany’s largest drugmaker said in a statement on Monday. Brandicourt, who was a member of Pfizer’s executive leadership team, will be responsible for taking new drugs to market, including stroke prevention pill Xarelto, eye drug Eylea and cancer treatment Stivarga and to translate successful drug trials into revenue growth.
Help employers find you! Check out all the jobs and post your resume.
